Biotech · Private company · Columbia, SC, US

Acepre, LLC

Track this companyFree. Adds Acepre, LLC to your Dealase workspace and tells you when its record changes.

Clinical trials0None registered

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

NIH awards4

Develop a novel strategy to deliver N-acetylcysteine for AD treatmentFiscal year 2024 · $499.4KNIH RePORTER 1R41AG087769-01A1 · fetched Nov 12, 2026
Develop natural compound emodin as a novel therapy for calcific aortic valve diseaseFiscal year 2024 · $300KNIH RePORTER 1R41HL172481-01 · fetched Nov 12, 2026
Targeting macrophage maladaptation for bacterial sepsis treatmentFiscal year 2024 · $297.3KNIH RePORTER 5R41AI174362-02 · fetched Nov 12, 2026
Developing natural compound emodin as a therapy for alcoholic cardiomyopathyFiscal year 2024 · $461.5KNIH RePORTER 5UT1AA030690-02 · fetched Nov 12, 2026